Want to see SE:MCAP full AI Analyst Report?
MedCap AB (MCAP) Ratios
MedCap AB Ratios
SE:MCAP's free cash flow for Q3 2026 was $91.80M. For the 2026 fiscal year, SE:MCAP's free cash flow was decreased by $-4.30M and operating cash flow was $96.10M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.01 | 2.77 | 2.23 | 2.46 | 1.96 |
| Quick Ratio | 1.46 | 1.96 | 1.42 | 1.92 | 1.34 |
| Cash Ratio | 0.75 | 1.12 | 0.55 | 0.78 | 0.58 |
| Solvency Ratio | 0.33 | 0.46 | 0.43 | 0.33 | 0.34 |
| Operating Cash Flow Ratio | 0.69 | 1.09 | 0.66 | 0.28 | 0.48 |
| Short-Term Operating Cash Flow Coverage | 5.78 | 14.29 | 5.43 | 0.97 | 1.74 |
| Net Current Asset Value | $ -155.70M | $ 214.20M | $ 130.10M | $ 171.20M | $ 3.10M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.19 | 0.18 | 0.16 | 0.24 | 0.22 |
| Debt-to-Equity Ratio | 0.33 | 0.28 | 0.26 | 0.40 | 0.37 |
| Debt-to-Capital Ratio | 0.25 | 0.22 | 0.20 | 0.28 | 0.27 |
| Long-Term Debt-to-Capital Ratio | 0.10 | 0.04 | 0.07 | 0.10 | 0.03 |
| Financial Leverage Ratio | 1.79 | 1.55 | 1.62 | 1.67 | 1.68 |
| Debt Service Coverage Ratio | 4.47 | 7.77 | 5.07 | 1.94 | 2.26 |
| Interest Coverage Ratio | 9.53 | 14.33 | 14.58 | 10.42 | 13.51 |
| Debt to Market Cap | 0.03 | 0.01 | 0.02 | 0.06 | 0.03 |
| Interest Debt Per Share | 34.33 | 25.44 | 18.69 | 24.07 | 17.99 |
| Net Debt to EBITDA | 0.24 | -0.03 | 0.21 | 0.44 | 0.61 |
| Profitability Margins | |||||
| Gross Profit Margin | 15.23% | 58.51% | 58.36% | 41.61% | 40.36% |
| EBIT Margin | 15.20% | 15.53% | 14.99% | 15.15% | 13.79% |
| EBITDA Margin | 22.48% | 21.92% | 21.54% | 21.35% | 20.90% |
| Operating Profit Margin | 14.24% | 15.07% | 14.33% | 15.38% | 13.86% |
| Pretax Profit Margin | 13.71% | 14.48% | 14.00% | 13.68% | 12.77% |
| Net Profit Margin | 10.43% | 11.48% | 10.85% | 10.58% | 10.53% |
| Continuous Operations Profit Margin | 10.47% | 11.58% | 10.87% | 10.62% | 10.71% |
| Net Income Per EBT | 76.06% | 79.28% | 77.46% | 77.37% | 82.48% |
| EBT Per EBIT | 96.27% | 96.07% | 97.71% | 88.94% | 92.13% |
| Return on Assets (ROA) | 8.43% | 10.41% | 10.36% | 8.23% | 8.25% |
| Return on Equity (ROE) | 15.14% | 16.18% | 16.83% | 13.73% | 13.86% |
| Return on Capital Employed (ROCE) | 14.22% | 16.40% | 17.25% | 15.16% | 13.69% |
| Return on Invested Capital (ROIC) | 10.35% | 12.66% | 12.72% | 10.67% | 10.45% |
| Return on Tangible Assets | 15.96% | 15.66% | 17.00% | 11.90% | 13.19% |
| Earnings Yield | 2.67% | 2.33% | 3.45% | 3.67% | 3.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.44 | 7.56 | 6.70 | 5.57 | 5.52 |
| Payables Turnover | 5.10 | 10.31 | 7.30 | 8.56 | 10.93 |
| Inventory Turnover | 6.58 | 2.79 | 2.39 | 3.99 | 3.64 |
| Fixed Asset Turnover | 5.56 | 4.49 | 6.51 | 4.58 | 3.61 |
| Asset Turnover | 0.81 | 0.91 | 0.95 | 0.78 | 0.78 |
| Working Capital Turnover Ratio | 3.89 | 3.58 | 3.68 | 3.30 | 4.59 |
| Cash Conversion Cycle | 32.86 | 143.84 | 157.26 | 114.36 | 133.09 |
| Days of Sales Outstanding | 49.04 | 48.30 | 54.49 | 65.49 | 66.16 |
| Days of Inventory Outstanding | 55.43 | 130.93 | 152.79 | 91.50 | 100.32 |
| Days of Payables Outstanding | 71.61 | 35.40 | 50.03 | 42.63 | 33.39 |
| Operating Cycle | 104.47 | 179.24 | 207.29 | 156.99 | 166.48 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 22.87 | 24.29 | 15.40 | 5.77 | 7.86 |
| Free Cash Flow Per Share | 18.72 | 19.83 | 12.74 | 2.78 | 3.74 |
| Dividend Paid and CapEx Coverage Ratio | 5.51 | 5.44 | 5.80 | 1.93 | 1.91 |
| Capital Expenditure Coverage Ratio | 5.51 | 5.44 | 5.80 | 1.93 | 1.91 |
| Operating Cash Flow Coverage Ratio | 0.71 | 1.01 | 0.87 | 0.25 | 0.45 |
| Operating Cash Flow to Sales Ratio | 0.16 | 0.20 | 0.14 | 0.08 | 0.13 |
| Free Cash Flow Yield | 3.41% | 3.30% | 3.78% | 1.29% | 2.10% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 37.42 | 42.96 | 29.02 | 27.26 | 27.30 |
| Price-to-Sales (P/S) Ratio | 3.90 | 4.93 | 3.15 | 2.88 | 2.88 |
| Price-to-Book (P/B) Ratio | 5.67 | 6.95 | 4.89 | 3.74 | 3.79 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 29.33 | 30.31 | 26.48 | 77.81 | 47.56 |
| Price-to-Operating Cash Flow Ratio | 24.01 | 24.74 | 21.92 | 37.49 | 22.65 |
| Price-to-Earnings Growth (PEG) Ratio | 7.70 | 2.12 | 0.62 | 1.25 | 0.51 |
| Enterprise Value Multiple | 17.60 | 22.46 | 14.83 | 13.95 | 14.37 |
| Enterprise Value | 8.34B | 8.89B | 5.07B | 3.31B | 2.75B |
| EV to EBITDA | 17.60 | 22.46 | 14.83 | 13.95 | 14.37 |
| EV to Sales | 3.96 | 4.92 | 3.19 | 2.98 | 3.00 |
| EV to Free Cash Flow | 29.73 | 30.27 | 26.87 | 80.33 | 49.67 |
| EV to Operating Cash Flow | 24.33 | 24.70 | 22.24 | 38.71 | 23.66 |
| Tangible Book Value Per Share | 15.34 | 41.92 | 25.52 | 28.18 | 17.55 |
| Shareholders’ Equity Per Share | 96.90 | 86.52 | 69.08 | 57.83 | 47.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.20 | 0.22 | 0.22 | 0.16 |
| Revenue Per Share | 140.67 | 121.93 | 107.20 | 75.06 | 61.90 |
| Net Income Per Share | 14.67 | 14.00 | 11.63 | 7.94 | 6.52 |
| Tax Burden | 0.76 | 0.79 | 0.77 | 0.77 | 0.82 |
| Interest Burden | 0.90 | 0.93 | 0.93 | 0.90 | 0.93 |
| Research & Development to Revenue | 0.03 | 0.02 | 0.01 | 0.03 | 0.02 |
| SG&A to Revenue | -0.02 | 0.39 | 0.00 | 0.00 | 0.12 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Income Quality | 1.13 | 1.32 | 1.32 | 0.50 | 0.92 |
Currency in SEK
